YOUTH WITH DIABETES WHO ARE INVOLVED IN THE DECISION TO START CONTINUOUS GLUCOSE MONITORING ARE MORE LIKELY TO CONTINUE USING IT, CHILDREN’S HOSPITAL OF PHILADELPHIA

$7.2M GRANT FROM NATIONAL INSTITUTE ON DRUG ABUSE ALLOWS TEMPLE SCIENTISTS TO CONTINUE CRITICAL RESEARCH ON DRUGS OF ABUSE, TEMPLE UNIVERSITY

TEMPLE SCIENTISTS IDENTIFY KEY FACTOR REGULATING ABNORMAL HEART GROWTH, TEMPLE UNIVERSITY

REACTIVE ARTHRITIS IS FUELED BY AMYLOID PROTEIN DURING SALMONELLA INFECTION, TEMPLE SCIENTISTS REPORT, TEMPLE UNIVERSITY

TEMPLE RECEIVES $12M NIH GRANT TO RESEARCH MOLECULAR BASIS OF HEART DISEASE AND PURSUE INNOVATIVE THERAPIES, TEMPLE UNIVERSITY

HERSHEY MEDICAL CENTER CARDIAC REHAB PROGRAM WINS REACCREDITATION, PENN STATE HEALTH

SPOTLIGHT ON WISTAR COVID-19 RESEARCHER: PAUL LIEBERMAN, PH.D., THE WISTAR INSTITUTE

WORKFORCE DEVELOPMENT AT WISTAR: LIFE SCIENCE STUDENTS GAIN VALUABLE RESEARCH EXPERIENCE DURING THE COVID-19 PANDEMIC, THE WISTAR INSTITUTE

NEW RESEARCH HIGHLIGHTS A RARE GENE MUTATION LINKED TO CANCER RISK IN THE ASHKENAZI JEWISH POPULATION, THE WISTAR INSTITUTE

THE WISTAR INSTITUTE AND CHEYNEY UNIVERSITY FORGE STRATEGIC COLLABORATION TO EXPAND LIFE SCIENCE RESEARCH TRAINING AND BUSINESS DEVELOPMENT OPPORTUNITIES IN PENNSYLVANIA, THE WISTAR INSTITUTE